...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Question for the board!

,,I didnt say we had to list on the Venture,,we could list on the US exchanges or the Hong Kong,,or any of the overseas markets in the future for that matter. My point is Zenith has been under thumb for 5 1/2 years...with no milestone cast yet in regards to a listing. Just the same old carrot offering from DM,,,and dont knock the venture,,,it has turned many a weak account into what one might say is sizable and respecfull. And one can always graduate from the Venture to the TSX to the Nasdaq when applicable. I was hoping to be able to use some of my $$$ invested in ZENE before I become worm food. Plus its just an opinion. I dont like my dollars being controlled by a thrid party,,never did,,and probably never will.

Share
New Message
Please login to post a reply